Pacific Gold Corp. (PINK:PCFG)(OTCQB:PCFG) reached up 12.50% in morning trading to $.045 with 1M shares traded. Pacific Gold Corp.'s business plan provides for the acquisition and development of production-ready and in-production mining operations. The company is focused on alluvial gold and base metals operations located in western North America. Pacific Gold Corp. owns four operating subsidiaries: Nevada Rae Gold, Inc., which owns and operates the Black Rock Canyon gold mine, located in north-central Nevada; Pilot Mountain Resources Inc., which owns Project W, a large tungsten based deposit in Nevada; Fernley Gold, Inc., which has acquired exclusive lease rights to mine the Lower Olinghouse Placers in north-western Nevada; and Pacific Metals Corp., which owns claims in San Juan and Delores Counties, Colorado, encompassing the historic Graysill Mine. Pacific Gold Corp. (PINK SHEETS: PCFG)(OTCQB: PCFG.PK - News) yesterday announced its subsidiary Pilot Mountain Resources, Inc. ("PMR") has settled its Quiet Title action with Platoro West Inc. ("Platoro"), Wolfranium Resource Corporation, and William Sheriff.
DARA BioSciences, Inc. (Nasdaq:DARA) reached up 25.88% in morning trading to $2.87 with 650K shares traded. DARA is a pharmaceutical development company that acquires high quality, promising therapeutic molecules in early stage development (late pre-clinical/Phase I) that has the potential to fill a significant medical need and represents a large commercial opportunity for participation in large and growing markets. The Company expedites development through proof-of-concept in humans (prior to Phase III) for subsequent partnering, sale or out-licensing to large healthcare and pharmaceutical companies. The effective implementation of this strategy has the potential to greatly enhance return on investment by properly designing drug studiers that will reduce event risks and cost of the drug development process. DARA BioSciences, Inc. (Nasdaq:DARA - News) announced today that its investigational drug KRN5500 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of chemotherapy-induced neuropathic pain in patients with cancer.
Omni Ventures, Inc. (PINK:OMVE) reached up 11.08% in morning trading to $.40 with 60K shares traded. Omni Ventures, Inc. is a development stage company working on a versatile portfolio of projects in premium consumer brands development and merchandising as well as consumer services. The Company is working to position itself as a strategic management holding company for several subsidiaries including the ones to be established or acquired. Currently the Company wholly owns PRVCY Couture, Inc., the casual couture apparel and accessories design, manufacturing and distribution company (www.prvcypremium.com). Management is negotiating several joint ventures with established operating companies in the fields of consumer goods design, manufacturing and distribution as well as consumer services. Omni Ventures, Inc. (Pink Sheets:OMVE) announced today the appointment of Mr. Paul Guez to the Board of Directors. Mr. Guez replaces Mr. D. Reardon as Chairman.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com
is not a registered investment advisers or broker/dealer. PennyTrader.com makes
no recommendation that the purchase of securities of companies profiled in this
press release is suitable or advisable for any person or that an investment
such securities will be profitable. In general, given the nature of the micro
cap companies covered and the potential lack of an active trading market their
securities, investing in such securities is highly speculative and carries a
high degree of risk. For our full disclaimer go to CLICK
HERE
